Description
Linagliptin and empagliflozin are medications used to treat type 2 diabetes. This combination is also used to reduce the risk of heart attack and stroke in people with type 2 diabetes.
How it works
- Empagliflozin: Works in the kidneys to prevent glucose (blood sugar) from being absorbed
- Linagliptin: Helps control blood sugar levels by increasing the amount of insulin released by the pancreas
Benefits
- Helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems
- May reduce the risk of heart attack or stroke
Additional information
| brand | Ccl |
|---|
